Public-sector procurement of Deferasirox is typically conducted through competitive tenders with strict documentation, pricing and delivery requirements. This guide summarises what buyers should expect.
1. Typical Tender Structure #
- Technical bid (dossier, licences, quality evidence)
- Commercial bid (pricing, Incoterms, payment terms)
- Delivery plan and penalty framework
2. Mandatory Documentation #
| Document | Purpose |
|---|---|
| WHO-GMP Certificate | Manufacturing quality evidence |
| CoPP (WHO format) | Product registration in home country |
| Free Sale Certificate | Legal marketing in origin country |
| CoA (per batch) | Batch-specific release data |
| Stability summary | Shelf-life justification |
| Bioequivalence summary | Generic equivalence vs reference |
3. Evaluation Criteria #
- Quality compliance (WHO-GMP, local registration, past-supply track record)
- Technical score (dossier completeness, SmPC alignment)
- Price (most competitive wins, subject to technical pass)
- Delivery reliability (lead times, penalty acceptance)
4. Practical Tips for Buyers #
- Engage qualified manufacturers early - not just traders - to verify capacity
- Confirm the manufacturer's safety-stock policy for priority awards
- Request manufacturer-signed Quality Agreement on award
- Insist on weekly production reporting during delivery window
- Ensure pharmacovigilance interface is documented in award contract
5. Common Pitfalls #
- Trader-only bids with no direct manufacturer accountability
- Undocumented lead times that slip after award
- Missing language-localised inserts delaying customs release
- Price-only selection ignoring quality differentiation
Taj Pharma participates in tenders globally - see Tender Supply.